{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:55Z","timestamp":1792671535923,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:00:00Z","timestamp":1593302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1704500"],"award-info":[{"award-number":["2018YFC1704500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["CPU2018GY03"],"award-info":[{"award-number":["CPU2018GY03"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.apsb.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T02:29:15Z","timestamp":1593656955000},"page":"1397-1413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":225,"title":["Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaowei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.06.015_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2020.06.015_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","article-title":"Sorafenib: a review of its use in advanced hepatocellular carcinoma","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2020.06.015_bib3","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.31963","article-title":"Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma","volume":"144","author":"Augello","year":"2019","journal-title":"Int J Canc"},{"key":"10.1016\/j.apsb.2020.06.015_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2020.06.015_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomized, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2020.06.015_bib6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2020.06.015_bib7","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.06.015_bib8","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2012.48.4410","article-title":"Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study","volume":"31","author":"Johnson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2020.06.015_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1470-2045(15)00050-9","article-title":"Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomized, double-blind, multicenter, phase 3 trial","volume":"16","author":"Zhu","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2020.06.015_bib10","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ijc.31022","article-title":"By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma","volume":"141","author":"Li","year":"2017","journal-title":"Int J Canc"},{"key":"10.1016\/j.apsb.2020.06.015_bib11","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2012.45.8372","article-title":"Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial","volume":"31","author":"Cheng","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2020.06.015_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2020.06.015_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.06.015_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/cr.2016.100","article-title":"Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2020.06.015_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.06.015_bib16","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.06.015_bib17","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/rcm.4195","article-title":"Characterization of tanshinones with quinone reductase induction activity from Radix Salvia miltiorrhiza by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Ma","year":"2009","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.apsb.2020.06.015_bib18","doi-asserted-by":"crossref","first-page":"20585","DOI":"10.1038\/srep20585","article-title":"Miltirone exhibits antileukemic activity by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2020.06.015_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.lfs.2016.02.083","article-title":"Miltirone induced mitochondrial dysfunction and ROS-dependent apoptosis in colon cancer cells","volume":"151","author":"Wang","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2020.06.015_bib20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/acs.jnatprod.5b00158","article-title":"Miltirone induces G2\/M cell cycle arrest and apoptosis in CCRF-CEM acute lymphoblastic leukemia cells","volume":"78","author":"Wu","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2020.06.015_bib21","first-page":"8841","article-title":"Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways","volume":"15","author":"Zhu","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2020.06.015_bib22","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/acs.jnatprod.5b00516","article-title":"Miltirone is a dual inhibitor of P glycoprotein and cell growth in doxorubicin-resistant HepG2 cells","volume":"78","author":"Zhou","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2020.06.015_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jssc.201800895","article-title":"Discovery of cancer cell proliferation inhibitors from Salviae miltiorrhizae radix et rhizome by a trace peak enrichment approach","volume":"42","author":"Zhang","year":"2019","journal-title":"J Separ Sci"},{"key":"10.1016\/j.apsb.2020.06.015_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2014.10.008","article-title":"A simple and sensitive LC\u2013MS\/MS method for determination of miltirone in rat plasma and its application to pharmacokinetic studies","volume":"973C","author":"Guo","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.apsb.2020.06.015_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.apsb.2020.06.015_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1053\/j.gastro.2017.07.036","article-title":"Inhibition of aurora kinase a induces necroptosis in pancreatic carcinoma","volume":"153","author":"Xie","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2020.06.015_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.06.015_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/2503","article-title":"Nonsyndromic hearing impairment is associated with a mutation in DFNA5","volume":"20","author":"Van Laer","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2020.06.015_bib29","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1158\/1078-0432.CCR-18-1478","article-title":"Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death","volume":"24","author":"Lu","year":"2018","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.apsb.2020.06.015_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.015_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-019-1492-6","article-title":"\u03b2-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38\/ERK MAPK signaling in human hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2020.06.015_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ol.2017.5557","article-title":"Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma","volume":"13","author":"Yang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2020.06.015_bib33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","article-title":"Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma","volume":"129","author":"Liu","year":"2011","journal-title":"Int J Canc"},{"key":"10.1016\/j.apsb.2020.06.015_bib34","first-page":"1195","article-title":"Vertical targeting of AKT and mTOR as well as dual targeting of AKT and MEK signaling is synergistic in hepatocellular carcinoma","volume":"6","author":"Ewald","year":"2015","journal-title":"J Canc"},{"key":"10.1016\/j.apsb.2020.06.015_bib35","first-page":"425","article-title":"Cancer statistics for hispanics\/latinos","volume":"68","author":"Miller","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2020.06.015_bib36","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2020.06.015_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","article-title":"Hepatocellular carcinoma: from diagnosis to treatment","volume":"25","author":"Grandhi","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.apsb.2020.06.015_bib38","doi-asserted-by":"crossref","first-page":"W88","DOI":"10.2214\/AJR.15.15490","article-title":"Current guidelines for the diagnosis and management of hepatocellular carcinoma: a comparative review","volume":"207","author":"Arslanoglu","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.apsb.2020.06.015_bib39","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/hep.26224","article-title":"Hypoxia-mediated sorafenib resistance can be overcome by EF24 through von Hippel-Lindau tumor suppressor-dependent HIF-1a inhibition in hepatocellular carcinoma","volume":"57","author":"Liang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2020.06.015_bib40","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0962-8924(01)02124-9","article-title":"Apoptosis and cancer chemotherapy","volume":"11","author":"Makin","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2020.06.015_bib41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","article-title":"Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPK\u03b1\/UCP2 pathway","volume":"9","author":"Hu","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.06.015_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/IAI.00905-09","article-title":"Pore formation triggered by Legionella spp. is an Nlrc4 inflammasome-dependent host cell response that precedes pyroptosis","volume":"78","author":"Silveira","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.apsb.2020.06.015_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41419-019-1441-4","article-title":"Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2020.06.015_bib44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.06.015_bib45","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signaling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2020.06.015_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/bbrc.1997.6840","article-title":"Increased MAPK expression and activity in primary human hepatocellular carcinoma","volume":"236","author":"Schmidt","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.06.015_bib47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.510270409","article-title":"Activation of mitogen-activated protein kinases\/extracellular signal-regulated kinases in human hepatocellular carcinoma","volume":"27","author":"Ito","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2020.06.015_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/abio.1998.3030","article-title":"A scintillation proximity assay for the Raf\/MEK\/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors","volume":"268","author":"McDonald","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.apsb.2020.06.015_bib49","doi-asserted-by":"crossref","first-page":"39435","DOI":"10.1074\/jbc.M004583200","article-title":"Requirement for ERK activation in cisplatin-induced apoptosis","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.06.015_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.apsb.2020.06.015_bib51","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1002\/jcp.25773","article-title":"Acetoacetate induces hepatocytes apoptosis by the ROS-mediated MAPKs pathway in ketotic cows","volume":"232","author":"Du","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2020.06.015_bib52","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","article-title":"Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis","volume":"28","author":"Zhou","year":"2018","journal-title":"Cell Res"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520306250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520306250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:17Z","timestamp":1761928997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520306250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2211383520306250"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.06.015","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}